BIOLASE, Inc. (BIOLQ)

Market Cap	37.00
Revenue (ttm)	46.03M
Net Income (ttm)	-15.97M
Shares Out	36.60M
EPS (ttm)	-0.71
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,510
Average Volume	15,257
Open	0.0000
Previous Close	0.0000
Day's Range	0.0000 - 0.0000
52-Week Range	0.0000 - 0.0200
Beta	-0.20
RSI	38.63
Earnings Date	n/a

About BIOLASE

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company provides Waterlase (all-tissue) systems for cutting soft and hard tissue; and diode (s...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1984
• Employees: 157
• Stock Exchange: OTCMKTS
• Ticker Symbol: BIOLQ

Financial Performance

In 2023, BIOLASE's revenue was $49.16 million, an increase of 1.45% compared to the previous year's $48.46 million. Losses were -$37.62 million, 30.4% more than in 2022.